SlideShare a Scribd company logo
1 of 78
33.1 Airborne Pathogens
• Aerosols are important for person-to-person
transmission of many infectious diseases
• Most pathogens survive poorly in air, thus, are
effectively transmitted only over short distances
• Respiratory infections
– Different pathogens characteristically colonize the
respiratory tract at different levels
– The upper and lower respiratory tracts offer
different environments and favor different
microbes
© 2012 Pearson Education, Inc.
Figure 33.1
© 2012 Pearson Education, Inc.
33.2 Streptococcal Diseases
• Streptococcus pyogenes (group A Streptococcus;
GAS)
– Commonly found in low numbers in the upper
respiratory tract of healthy individuals
– Causative agent of “strep throat”
– Can also cause infections of the inner ear,
mammary glands, and skin
• Infections occur if host defenses are weakened or
a new, highly virulent strain is introduced
© 2012 Pearson Education, Inc.
Figure 33.3
© 2012 Pearson Education, Inc.
Figure 33.4
© 2012 Pearson Education, Inc.
Figure 33.5
© 2012 Pearson Education, Inc.
33.2 Streptococcal Diseases
• Streptococcus pyogenes (cont’d)
– Certain GAS strains carry a lysogenic
bacteriophage that encodes exotoxins responsible
for symptoms of toxic shock syndrome and scarlet
fever
– Untreated or insufficiently treated infections can
lead to other diseases (e.g., rheumatic fever)
© 2012 Pearson Education, Inc.
Figure 33.6
© 2012 Pearson Education, Inc.
33.3 Diphtheria and Pertussis
• Diphtheria
– A severe respiratory disease that typically
infects children
– Caused by Corynebacterium diphtheriae
• A bacterium that forms irregular rods during
growth
– Preventable and treatable
© 2012 Pearson Education, Inc.
Figure 33.7a
© 2012 Pearson Education, Inc.
33.3 Diphtheria and Pertussis
• Corynebacterium diphtheriae
– Spreads by airborne droplets and enters the body
via the respiratory route
– Previous infection or immunization provides
resistance
– Pathogenic strains lysogenized by bacteriophage
 produce a powerful exotoxin that causes
• Tissue death
• The appearance of the pseudomembrane in the
patient’s throat
© 2012 Pearson Education, Inc.
Figure 33.7b
© 2012 Pearson Education, Inc.
33.3 Diphtheria and Pertussis
• Diagnosis of Diphtheria
– C. diphtheriae must be isolated from the throat
• Prevention of Diphtheria
– Vaccine
• Treatment of Diphtheria
– Antibiotics
– Diphtheria antitoxin available for acute cases
• Early administration necessary
© 2012 Pearson Education, Inc.
33.3 Diphtheria and Pertussis
• Pertussis (whooping cough)
– An acute, highly infectious respiratory disease
– Caused by infection with Bordetella pertussis
– Observed frequently in school-age children
– Characterized by a recurrent, violent cough
– There has been a consistent upward trend of
infections since the 1980s
– Inadequately immunized children, adolescents,
and adults are at high risk for acquiring and
spreading pertussis
© 2012 Pearson Education, Inc.
Figure 33.8
Year
1977 1982 1987 1992 1997 2002 2007
9
8
7
6
5
4
3
2
1
0
Pertussis
(incidence
per
100,000
population)
© 2012 Pearson Education, Inc.
33.3 Diphtheria and Pertussis
• Diagnosis
– Made by fluorescent antibody staining of a
nasopharyngeal swab specimen
– Also made by actual culture of the organism
• Prevention
– Vaccine soon after birth
• Treatment
– Antibiotics
– But elimination is helped by the immune response
© 2012 Pearson Education, Inc.
33.4 Mycobacterium, Tuberculosis, and
Hansen’s Disease
• Tuberculosis is caused by Mycobacterium
tuberculosis
• Hansen’s disease (leprosy) is caused by
Mycobacterium leprae
• All mycobacteria are acid-fast due to the
waxy mycolic acid content of their cell walls
© 2012 Pearson Education, Inc.
Figure 33.9
© 2012 Pearson Education, Inc.
33.4 Mycobacterium, Tuberculosis, and
Hansen’s Disease
• Tuberculosis
– Worldwide infectious disease of humans
– Incidence is increasing
– M. tuberculosis transmitted by airborne droplets
– Cell-mediated immunity plays a critical role in
the prevention of active disease after infection
– Classified as a primary (initial) infection or
postprimary infection (reinfection)
© 2012 Pearson Education, Inc.
Figure 33.10
© 2012 Pearson Education, Inc.
33.4 Mycobacterium, Tuberculosis, and
Hansen’s Disease
• Spread of tuberculosis is prevented by
– Hospitalization of patients in negative-pressure
rooms
– Use of face masks for healthcare workers
• Treatment
– Antimicrobial therapy with isoniazid
• Treatment usually requires a 9-month regimen
• Affects the synthesis of mycolic acid in
mycobacteria
© 2012 Pearson Education, Inc.
33.4 Mycobacterium, Tuberculosis, and
Hansen’s Disease
• Hansen’s disease (leprosy)
– M. leprae is the causative agent
– The armadillo is the only experimental animal
that has been successfully used to grow
M. leprae
– Most serious form is characterized by folded,
bulblike lesions on the body
© 2012 Pearson Education, Inc.
Figure 33.12
© 2012 Pearson Education, Inc.
33.4 Mycobacterium, Tuberculosis, and
Hansen’s Disease
• Pathogenicity of M. leprae
– Due to a combination of delayed hypersensitivity
and the invasiveness of the organism
– Transmission is by both direct contact and
respiratory routes
– Incubation times vary from several weeks to years
– The incidence of leprosy worldwide is low
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• Viruses are less easily controlled by
chemotherapeutic methods
• The most prevalent human infections are caused
by viruses
• Most viral diseases are acute, self-limiting
infections
• A few serious viral diseases have been effectively
controlled by vaccination (e.g., smallpox and
rabies)
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• Measles (rubeola or 7-day measles)
– Often affects susceptible children as an acute,
highly infectious, often epidemic disease
(Figure 33.14)
– Caused by a paramyxovirus
• Negative-strand RNA virus
– Virus enters the nose and throat by airborne
transmission
© 2012 Pearson Education, Inc.
Figure 33.14
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• Measles (cont’d)
– Used to be a common childhood illness
– Now only occurs in rather isolated outbreaks
• Due to widespread immunization programs that
began in the mid-1960s
– Over 600,000 deaths per year worldwide
– Proof of immunization required for enrollment in
U.S. public schools
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• Mumps
– Caused by a paramyxovirus (like measles)
– Highly infectious
– Spread by airborne droplets
– Characterized by inflammation of the salivary
glands
© 2012 Pearson Education, Inc.
Figure 33.16
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• Rubella (German measles or 3-day measles)
– Caused by a positive-strand RNA virus of the
togavirus group
– Disease symptoms resemble measles but are
generally milder and less contagious
– Routine childhood immunization is practiced in
the U.S.
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• In the U.S., the incidence of measles, mumps,
and rubella has decreased significantly since
the implementation of the MMR vaccine
© 2012 Pearson Education, Inc.
Figure 33.15
Measles
Mumps
Rubella
1987 1992 1997 2002 2007 2012
19651970197519801985
400
200
0
1987 1992 1997 2002 2007 2012
19651970197519801985
1987 1992 1997 2002 2007 2012
19651970197519801985
1960
150
100
50
0
0
10
20
30
25
20
15
10
5
0
5
6
7
4
3
2
1
0
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
Cases
per
100,000
population
Cases
per
100,000
population
Cases
per
100,000
population
Vaccine
licensed
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• Chicken pox (varicella)
– Common childhood disease characterized by a
systemic papular rash
– Caused by varicella-zoster virus (VZV), a
herpesvirus
– VZV is highly contagious and transmitted by
infectious droplets
– A vaccine is presently used in the U.S.
© 2012 Pearson Education, Inc.
Figure 33.17
© 2012 Pearson Education, Inc.
33.6 Viruses and Respiratory Infections
• Chicken pox (cont’d)
– VZV virus establishes a lifelong latent
infection in nerve cells
– The virus occasionally migrates to the skin
surface, causing a painful skin eruption
(shingles)
© 2012 Pearson Education, Inc.
33.7 Colds
• Colds
– Viral infections transmitted via airborne droplets
– Infections are usually of short duration
– Symptoms milder than other respiratory
diseases
– Symptoms include rhinitis, nasal obstruction,
watery nasal discharges, and malaise
© 2012 Pearson Education, Inc.
Figure 33.18
Cases per 100 people per year
All other infectious diseases
Colds
Influenza
400
300
200
100
0
© 2012 Pearson Education, Inc.
33.7 Colds
• The Common Cold
– Commonly caused by rhinoviruses (Figure 33.19)
• Positive-sense, single-stranded RNA viruses
• Nearly 115 different strains identified
– Approximately 15% of colds are due to
coronaviruses
– Approximately 10% of colds are due to other
viruses
© 2012 Pearson Education, Inc.
Figure 33.19
© 2012 Pearson Education, Inc.
33.7 Colds
• Each cold infection induces a specific,
protective immunity, but the large number of
viral cold pathogens precludes complete
protective immunity or vaccines
© 2012 Pearson Education, Inc.
33.8 Influenza
• Influenza is caused by an RNA virus of the
orthomyxovirus group
• There are three different types of influenza
viruses (A, B, C)
• Influenza A is the most important human
pathogen
© 2012 Pearson Education, Inc.
Figure 33.21
HA trimer
Lipid bilayer
M protein
NA tetramer
RNA
NP
PA, PB1, PB2
© 2012 Pearson Education, Inc.
33.8 Influenza
• Influenza outbreaks occur annually due to the
plasticity of the influenza genome
– Antigenic shift
• Major change in influenza virus antigen due to
gene reassortment (Figure 33.22)
– Antigenic drift
• Minor change in influenza virus antigens due to
gene mutation
© 2012 Pearson Education, Inc.
Figure 33.22
Reassortant
virus
Human
virus
Bird
virus
Infection
with
bird virus
Reassortment
of human and
bird virus
Infection with
human virus
Infection
with
reassortant
virus
© 2012 Pearson Education, Inc.
33.8 Influenza
• Influenza epidemics and pandemics occur
periodically
– 1957 outbreak of Asian flu
– 1997 outbreak of avian influenza
© 2012 Pearson Education, Inc.
Figure 33.23
Country of origin
Countrywide epidemic
Localized outbreaks
Routes of spread
© 2012 Pearson Education, Inc.
33.8 Influenza
• Prevention
– Immunization
– Careful worldwide surveillance
• Treatment
– Use of various drugs
– Most effective when administered early
– Aspirin should be avoided
© 2012 Pearson Education, Inc.
33.11 Hepatitis Viruses
• Hepatitis
– Liver inflammation caused by viruses or bacteria
– Sometimes results in acute illness followed by
destruction of liver anatomy and cells (cirrhosis)
– A restricted group of viruses is associated with
liver disease
– Hepatitis viruses are diverse
© 2012 Pearson Education, Inc.
33.11 Hepatitis Viruses
• Hepatitis A virus (infectious hepatitis)
– Causes mild or, rarely, severe cases of liver
disease
• Hepatitis B virus (serum hepatitis; Figure 33.27)
– Causes acute, often severe disease that can lead
to liver failure and death
• Hepatitis D virus
– A defective virus that cannot replicate and
express a complete virus unless the cell is also
infected with hepatitis B
© 2012 Pearson Education, Inc.
Figure 33.27
© 2012 Pearson Education, Inc.
33.11 Hepatitis Viruses
• Hepatitis C virus
– Produces a mild disease initially, but most
individuals develop chronic hepatitis that can lead
to chronic liver disease
© 2012 Pearson Education, Inc.
33.11 Hepatitis Viruses
• Incidence and Prevalence of Hepatitis
– Decreased significantly in the U.S. in the last
20 years (Figure 33.26)
– Viral hepatitis is still a major public health
problem
• Due to the high infectivity of the viruses and the
lack of effective treatment options
– Vaccines are available for Hepatitis A and B
viruses
© 2012 Pearson Education, Inc.
Figure 33.26
Hepatitis A
Hepatitis B
Hepatitis C
HAV vaccine
1995
HBV vaccine
1982
Year
Cases
per
100,000
population
20
15
10
5
0
1975 1980 1985 1990 1995 2000 2005 2010
© 2012 Pearson Education, Inc.
III. Sexually Transmitted Infections
• Sexually Transmitted Infections (STIs)
– Also called sexually transmitted diseases (STDs)
or venereal diseases
– Caused by a variety of bacteria, viruses, protists,
and even fungi
– Pathogens are generally only found in body fluids
from the genitourinary tract that are exchanged
during sexual activity
© 2012 Pearson Education, Inc.
33.12 Gonorrhea and Syphilis
• Gonorrhea and syphilis are preventable,
treatable bacterial STIs
• The overall pattern of disease differs between
the two
– Gonorrhea is prevalent and often
asymptomatic in women
– Syphilis has low prevalence and exhibits very
obvious symptoms
© 2012 Pearson Education, Inc.
Figure 33.28
Year
Birth control pills
Penicillin
World War II
Reported
cases
per
100,000
population
Syphilis
Gonorrhea
500
400
300
200
100
0
1920 1925 1930 1935 1940 1945 1950 1955 1960 1965 1970 1975 1980 1985 1990 1995 2000 2005 2010
© 2012 Pearson Education, Inc.
33.12 Gonorrhea and Syphilis
• Gonorrhea
– Caused by Neisseria gonorrhoeae
– Symptoms in females
• Characterized by a mild vaginitis that often goes
unnoticed
• Untreated gonorrhea can lead to pelvic
inflammatory disease
– Symptoms in males
• Characterized by a painful infection of the
urethral canal
© 2012 Pearson Education, Inc.
Figure 33.29
© 2012 Pearson Education, Inc.
33.12 Gonorrhea and Syphilis
• Syphilis
– Caused by Treponema pallidum
– Often transmitted at the same time as gonorrhea
– T. pallidum can be transmitted from an infected
woman to the fetus during pregnancy (congenital
syphilis)
– Three stages: primary, secondary, and tertiary
– Penicillin highly effective for primary and
secondary stages
© 2012 Pearson Education, Inc.
Figure 33.30
© 2012 Pearson Education, Inc.
33.13 Chlamydia, Herpes, and HPV
• Chlamydia trachomatis causes a number of
sexually transmitted diseases
– Nongonococcal urethritis (NGU)
– Lymphogranuloma venereum
© 2012 Pearson Education, Inc.
Figure 33.32
© 2012 Pearson Education, Inc.
33.13 Chlamydia, Herpes, Trichomoniasis,
and HPV
• Herpes simplex 1 virus (HSV-1)
– Infects the epithelial cells around the mouth
and lips
– Causes cold sores
– May occasionally affect other body sites
– Spread via direct contact or through saliva
– Lesions heal without treatment in 2 to 3 weeks
© 2012 Pearson Education, Inc.
33.13 Chlamydia, Herpes, Trichomoniasis,
and HPV
• Herpes simplex 2 virus (HSV-2)
– Infections are associated primarily with anogenital
region
– Causes painful blisters on penis of male and cervix,
vulva, or vagina of females
– Typically transmitted through sexual contact and
most easily transmitted when active blisters are
present
– Genital herpes are presently incurable, however, a
limited number of drugs are successful in controlling
the infectious blister stage
© 2012 Pearson Education, Inc.
33.13 Chlamydia, Herpes, Trichomoniasis,
and HPV
• Human papillomavirus (HPV)
– Causes several different infections
• Many infections are asymptomatic but some
progress to genital warts
• Can cause cervical neoplasia, and a few progress
to cervical cancers
– There is an effective HPV vaccine
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• AIDS
– Recognized as a distinct disease in 1981
– Human immunodeficiency virus (HIV) is the
causative agent
• HIV
– As many as 1.4 million people worldwide may
be infected
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• HIV is divided into two types:
– HIV-1 is the more virulent type
– HIV-2 is less virulent and causes a milder, AIDS-
like disease
• Opportunistic infections are common in AIDS
patients
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• A frequent nonmicrobial disease in AIDS
patients is Kaposi’s sarcoma, an atypical
cancer
© 2012 Pearson Education, Inc.
Figure 33.37
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• HIV Pathogenesis
– HIV infects cells that contain the CD4 cell surface
protein
– Most commonly infected are macrophages and
T-helper cells
– HIV also interacts with coreceptors on target cells
© 2012 Pearson Education, Inc.
Figure 33.38
Mature
form
Budding
particles
© 2012 Pearson Education, Inc.
Figure 33.39
Nucleocapsid
Nucleus
gp 120
CCR5
CD4
Target
cell
Interaction of HIV with a
host cell
Fusion of the HIV envelope with the host cell
HIV gp120 protein binds CD4
receptor and CCR5 receptor
Interaction of the
virus with a receptor–
coreceptor pair on
the host cell
The viral envelope
and host membrane
coalesce
The nucleocapsid
is inserted into
the host cell,
beginning the
viral infection
HIV
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• HIV infection does not immediately kill the
host cell
• Infection results in a progressive decline in
CD4 cells
• As the number of CD4 cells declines, cytokine
production falls, leading to reduction of the
immune response
© 2012 Pearson Education, Inc.
Figure 33.40
Symptom-
free
Swollen lymph glands Subclinical immune
dysfunction
Oppor-
tunistic
infections
Systemic
immune
deficiency
Time (months) after HIV exposure
HIV
RNA
copies
per
ml
Death
CD4
T cells
per
mm3 of
blood
Normal
range
for T cells
Significantly
depressed
T cells
Severe
T cell
depletion
106
104
102
1000
900
800
700
600
500
400
300
200
100
0
0 6 12 18 24 30 36 42 48 54 60 66 72 78 84
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• HIV infection can be diagnosed with an HIV-EIA,
HIV-immunoblot, or rapid tests
– These fail to detect infection in individuals who
recently acquired the HIV and have not made a
detectable antibody
• RT-PCR can detect HIV RNA directly from blood
and estimate the number of viruses present
– This is useful for early detection and monitoring
the progression of infection
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• Treatment
– Four classes of drugs delay the symptoms of
AIDS and prolong the life of those infected with
HIV
• Nucleoside reverse transcriptase inhibitors
• Nonnucleoside reverse transcriptase inhibitors
• Protease inhibitors
• Fusion inhibitors
– Highly active antiretroviral therapy (HAART) is
used
© 2012 Pearson Education, Inc.
33.14 Acquired Immunodeficiency
Syndrome: AIDS & HIV
• There is not an effective vaccine for HIV
• Prevention for the spread of HIV infection
requires education and avoidance of high-risk
behavior
© 2012 Pearson Education, Inc.

More Related Content

Similar to Diptheria host and pathogens with cause.ppt

Similar to Diptheria host and pathogens with cause.ppt (20)

4.mycology
4.mycology4.mycology
4.mycology
 
acute respiratory in fection in children
acute respiratory in fection in childrenacute respiratory in fection in children
acute respiratory in fection in children
 
epidemiology of common infectious diseases-resp,git,arthropod.pptx
epidemiology of common infectious diseases-resp,git,arthropod.pptxepidemiology of common infectious diseases-resp,git,arthropod.pptx
epidemiology of common infectious diseases-resp,git,arthropod.pptx
 
Measle.pdf
Measle.pdfMeasle.pdf
Measle.pdf
 
Share_smallpoxchickenpoxrizwan-160925004343.pdf
Share_smallpoxchickenpoxrizwan-160925004343.pdfShare_smallpoxchickenpoxrizwan-160925004343.pdf
Share_smallpoxchickenpoxrizwan-160925004343.pdf
 
Measals and there management
Measals and there managementMeasals and there management
Measals and there management
 
epidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdfepidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdf
 
Epidemiology of measles
Epidemiology of measlesEpidemiology of measles
Epidemiology of measles
 
Airborne diseases
Airborne diseasesAirborne diseases
Airborne diseases
 
MEASLES
MEASLESMEASLES
MEASLES
 
Influenza
InfluenzaInfluenza
Influenza
 
Airborne diseases
Airborne diseasesAirborne diseases
Airborne diseases
 
influeza and diptheria -Dr Krishna Smirthi CV.pptx
influeza and diptheria -Dr Krishna Smirthi CV.pptxinflueza and diptheria -Dr Krishna Smirthi CV.pptx
influeza and diptheria -Dr Krishna Smirthi CV.pptx
 
MEASLES.pptx4445544444444444444444444444
MEASLES.pptx4445544444444444444444444444MEASLES.pptx4445544444444444444444444444
MEASLES.pptx4445544444444444444444444444
 
Viral Diseases
Viral DiseasesViral Diseases
Viral Diseases
 
Lesson plan on influenza
Lesson plan on influenzaLesson plan on influenza
Lesson plan on influenza
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
 
Measles
Measles Measles
Measles
 
ADENOVIRUSES:DOUBLE STRANDED DNA VIRUSES.pptx
ADENOVIRUSES:DOUBLE STRANDED DNA VIRUSES.pptxADENOVIRUSES:DOUBLE STRANDED DNA VIRUSES.pptx
ADENOVIRUSES:DOUBLE STRANDED DNA VIRUSES.pptx
 
COMMUNIABLE DISEASE.pptx
COMMUNIABLE DISEASE.pptxCOMMUNIABLE DISEASE.pptx
COMMUNIABLE DISEASE.pptx
 

More from ShaliniN51

osteoradionecrosis-160118051248 new.pptx
osteoradionecrosis-160118051248 new.pptxosteoradionecrosis-160118051248 new.pptx
osteoradionecrosis-160118051248 new.pptxShaliniN51
 
Acne Vulgaris skin infections and disorders.pptx
Acne Vulgaris skin infections and disorders.pptxAcne Vulgaris skin infections and disorders.pptx
Acne Vulgaris skin infections and disorders.pptxShaliniN51
 
Inflamatory Markers CRP & ESR. Medical .pptx
Inflamatory Markers CRP & ESR. Medical .pptxInflamatory Markers CRP & ESR. Medical .pptx
Inflamatory Markers CRP & ESR. Medical .pptxShaliniN51
 
Lectures6and7Cytogenics wiliams disease.ppt
Lectures6and7Cytogenics wiliams disease.pptLectures6and7Cytogenics wiliams disease.ppt
Lectures6and7Cytogenics wiliams disease.pptShaliniN51
 
OCEF-2019-Dry-Eye-Clinical-Update n.pptx
OCEF-2019-Dry-Eye-Clinical-Update n.pptxOCEF-2019-Dry-Eye-Clinical-Update n.pptx
OCEF-2019-Dry-Eye-Clinical-Update n.pptxShaliniN51
 
2_2019_03_22!10_34_54_PM shigellosis.pptx
2_2019_03_22!10_34_54_PM shigellosis.pptx2_2019_03_22!10_34_54_PM shigellosis.pptx
2_2019_03_22!10_34_54_PM shigellosis.pptxShaliniN51
 
brucellosis and clinical features , .pdf
brucellosis and clinical features , .pdfbrucellosis and clinical features , .pdf
brucellosis and clinical features , .pdfShaliniN51
 
yellow-fever-disease on Cheat year and day
yellow-fever-disease on Cheat year and dayyellow-fever-disease on Cheat year and day
yellow-fever-disease on Cheat year and dayShaliniN51
 
Prostatitis-ppt (1).pptx
Prostatitis-ppt (1).pptxProstatitis-ppt (1).pptx
Prostatitis-ppt (1).pptxShaliniN51
 
Anxiety disorders.pptx
Anxiety disorders.pptxAnxiety disorders.pptx
Anxiety disorders.pptxShaliniN51
 
anxietydisorders-200225031301.pdf
anxietydisorders-200225031301.pdfanxietydisorders-200225031301.pdf
anxietydisorders-200225031301.pdfShaliniN51
 
urticaria-140703021029-phpapp02.pptx
urticaria-140703021029-phpapp02.pptxurticaria-140703021029-phpapp02.pptx
urticaria-140703021029-phpapp02.pptxShaliniN51
 
osteomalacia-2nd-150704155942-lva1-app6892.pptx
osteomalacia-2nd-150704155942-lva1-app6892.pptxosteomalacia-2nd-150704155942-lva1-app6892.pptx
osteomalacia-2nd-150704155942-lva1-app6892.pptxShaliniN51
 
nasalpolyps-151224095805.pptx
nasalpolyps-151224095805.pptxnasalpolyps-151224095805.pptx
nasalpolyps-151224095805.pptxShaliniN51
 
asthma-160424141552.pdf
asthma-160424141552.pdfasthma-160424141552.pdf
asthma-160424141552.pdfShaliniN51
 
hidradenitissuppurativa-170104084033.pptx
hidradenitissuppurativa-170104084033.pptxhidradenitissuppurativa-170104084033.pptx
hidradenitissuppurativa-170104084033.pptxShaliniN51
 
inflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdfinflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdfShaliniN51
 
psoriasis-160716060900.pdf
psoriasis-160716060900.pdfpsoriasis-160716060900.pdf
psoriasis-160716060900.pdfShaliniN51
 
MOLECULAR BASIS OF MEMORY.pptx
MOLECULAR BASIS OF MEMORY.pptxMOLECULAR BASIS OF MEMORY.pptx
MOLECULAR BASIS OF MEMORY.pptxShaliniN51
 

More from ShaliniN51 (19)

osteoradionecrosis-160118051248 new.pptx
osteoradionecrosis-160118051248 new.pptxosteoradionecrosis-160118051248 new.pptx
osteoradionecrosis-160118051248 new.pptx
 
Acne Vulgaris skin infections and disorders.pptx
Acne Vulgaris skin infections and disorders.pptxAcne Vulgaris skin infections and disorders.pptx
Acne Vulgaris skin infections and disorders.pptx
 
Inflamatory Markers CRP & ESR. Medical .pptx
Inflamatory Markers CRP & ESR. Medical .pptxInflamatory Markers CRP & ESR. Medical .pptx
Inflamatory Markers CRP & ESR. Medical .pptx
 
Lectures6and7Cytogenics wiliams disease.ppt
Lectures6and7Cytogenics wiliams disease.pptLectures6and7Cytogenics wiliams disease.ppt
Lectures6and7Cytogenics wiliams disease.ppt
 
OCEF-2019-Dry-Eye-Clinical-Update n.pptx
OCEF-2019-Dry-Eye-Clinical-Update n.pptxOCEF-2019-Dry-Eye-Clinical-Update n.pptx
OCEF-2019-Dry-Eye-Clinical-Update n.pptx
 
2_2019_03_22!10_34_54_PM shigellosis.pptx
2_2019_03_22!10_34_54_PM shigellosis.pptx2_2019_03_22!10_34_54_PM shigellosis.pptx
2_2019_03_22!10_34_54_PM shigellosis.pptx
 
brucellosis and clinical features , .pdf
brucellosis and clinical features , .pdfbrucellosis and clinical features , .pdf
brucellosis and clinical features , .pdf
 
yellow-fever-disease on Cheat year and day
yellow-fever-disease on Cheat year and dayyellow-fever-disease on Cheat year and day
yellow-fever-disease on Cheat year and day
 
Prostatitis-ppt (1).pptx
Prostatitis-ppt (1).pptxProstatitis-ppt (1).pptx
Prostatitis-ppt (1).pptx
 
Anxiety disorders.pptx
Anxiety disorders.pptxAnxiety disorders.pptx
Anxiety disorders.pptx
 
anxietydisorders-200225031301.pdf
anxietydisorders-200225031301.pdfanxietydisorders-200225031301.pdf
anxietydisorders-200225031301.pdf
 
urticaria-140703021029-phpapp02.pptx
urticaria-140703021029-phpapp02.pptxurticaria-140703021029-phpapp02.pptx
urticaria-140703021029-phpapp02.pptx
 
osteomalacia-2nd-150704155942-lva1-app6892.pptx
osteomalacia-2nd-150704155942-lva1-app6892.pptxosteomalacia-2nd-150704155942-lva1-app6892.pptx
osteomalacia-2nd-150704155942-lva1-app6892.pptx
 
nasalpolyps-151224095805.pptx
nasalpolyps-151224095805.pptxnasalpolyps-151224095805.pptx
nasalpolyps-151224095805.pptx
 
asthma-160424141552.pdf
asthma-160424141552.pdfasthma-160424141552.pdf
asthma-160424141552.pdf
 
hidradenitissuppurativa-170104084033.pptx
hidradenitissuppurativa-170104084033.pptxhidradenitissuppurativa-170104084033.pptx
hidradenitissuppurativa-170104084033.pptx
 
inflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdfinflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdf
 
psoriasis-160716060900.pdf
psoriasis-160716060900.pdfpsoriasis-160716060900.pdf
psoriasis-160716060900.pdf
 
MOLECULAR BASIS OF MEMORY.pptx
MOLECULAR BASIS OF MEMORY.pptxMOLECULAR BASIS OF MEMORY.pptx
MOLECULAR BASIS OF MEMORY.pptx
 

Recently uploaded

DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUMDEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUMELOISARIVERA8
 
Major project report on Tata Motors and its marketing strategies
Major project report on Tata Motors and its marketing strategiesMajor project report on Tata Motors and its marketing strategies
Major project report on Tata Motors and its marketing strategiesAmanpreetKaur157993
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽中 央社
 
An overview of the various scriptures in Hinduism
An overview of the various scriptures in HinduismAn overview of the various scriptures in Hinduism
An overview of the various scriptures in HinduismDabee Kamal
 
An Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge AppAn Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge AppCeline George
 
Scopus Indexed Journals 2024 - ISCOPUS Publications
Scopus Indexed Journals 2024 - ISCOPUS PublicationsScopus Indexed Journals 2024 - ISCOPUS Publications
Scopus Indexed Journals 2024 - ISCOPUS PublicationsISCOPE Publication
 
How to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptxHow to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptxCeline George
 
Book Review of Run For Your Life Powerpoint
Book Review of Run For Your Life PowerpointBook Review of Run For Your Life Powerpoint
Book Review of Run For Your Life Powerpoint23600690
 
ANTI PARKISON DRUGS.pptx
ANTI         PARKISON          DRUGS.pptxANTI         PARKISON          DRUGS.pptx
ANTI PARKISON DRUGS.pptxPoojaSen20
 
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of TransportBasic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of TransportDenish Jangid
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...Nguyen Thanh Tu Collection
 
MOOD STABLIZERS DRUGS.pptx
MOOD     STABLIZERS           DRUGS.pptxMOOD     STABLIZERS           DRUGS.pptx
MOOD STABLIZERS DRUGS.pptxPoojaSen20
 
e-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopale-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi RajagopalEADTU
 
Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppCeline George
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsSandeep D Chaudhary
 
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhĐề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhleson0603
 

Recently uploaded (20)

OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...
 
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUMDEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
 
Major project report on Tata Motors and its marketing strategies
Major project report on Tata Motors and its marketing strategiesMajor project report on Tata Motors and its marketing strategies
Major project report on Tata Motors and its marketing strategies
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
 
An overview of the various scriptures in Hinduism
An overview of the various scriptures in HinduismAn overview of the various scriptures in Hinduism
An overview of the various scriptures in Hinduism
 
An Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge AppAn Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge App
 
Scopus Indexed Journals 2024 - ISCOPUS Publications
Scopus Indexed Journals 2024 - ISCOPUS PublicationsScopus Indexed Journals 2024 - ISCOPUS Publications
Scopus Indexed Journals 2024 - ISCOPUS Publications
 
How to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptxHow to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptx
 
Book Review of Run For Your Life Powerpoint
Book Review of Run For Your Life PowerpointBook Review of Run For Your Life Powerpoint
Book Review of Run For Your Life Powerpoint
 
ANTI PARKISON DRUGS.pptx
ANTI         PARKISON          DRUGS.pptxANTI         PARKISON          DRUGS.pptx
ANTI PARKISON DRUGS.pptx
 
Mattingly "AI & Prompt Design: Named Entity Recognition"
Mattingly "AI & Prompt Design: Named Entity Recognition"Mattingly "AI & Prompt Design: Named Entity Recognition"
Mattingly "AI & Prompt Design: Named Entity Recognition"
 
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of TransportBasic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
MOOD STABLIZERS DRUGS.pptx
MOOD     STABLIZERS           DRUGS.pptxMOOD     STABLIZERS           DRUGS.pptx
MOOD STABLIZERS DRUGS.pptx
 
e-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopale-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopal
 
Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio App
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Mattingly "AI and Prompt Design: LLMs with NER"
Mattingly "AI and Prompt Design: LLMs with NER"Mattingly "AI and Prompt Design: LLMs with NER"
Mattingly "AI and Prompt Design: LLMs with NER"
 
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhĐề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 

Diptheria host and pathogens with cause.ppt

  • 1. 33.1 Airborne Pathogens • Aerosols are important for person-to-person transmission of many infectious diseases • Most pathogens survive poorly in air, thus, are effectively transmitted only over short distances • Respiratory infections – Different pathogens characteristically colonize the respiratory tract at different levels – The upper and lower respiratory tracts offer different environments and favor different microbes © 2012 Pearson Education, Inc.
  • 2. Figure 33.1 © 2012 Pearson Education, Inc.
  • 3. 33.2 Streptococcal Diseases • Streptococcus pyogenes (group A Streptococcus; GAS) – Commonly found in low numbers in the upper respiratory tract of healthy individuals – Causative agent of “strep throat” – Can also cause infections of the inner ear, mammary glands, and skin • Infections occur if host defenses are weakened or a new, highly virulent strain is introduced © 2012 Pearson Education, Inc.
  • 4. Figure 33.3 © 2012 Pearson Education, Inc.
  • 5. Figure 33.4 © 2012 Pearson Education, Inc.
  • 6. Figure 33.5 © 2012 Pearson Education, Inc.
  • 7. 33.2 Streptococcal Diseases • Streptococcus pyogenes (cont’d) – Certain GAS strains carry a lysogenic bacteriophage that encodes exotoxins responsible for symptoms of toxic shock syndrome and scarlet fever – Untreated or insufficiently treated infections can lead to other diseases (e.g., rheumatic fever) © 2012 Pearson Education, Inc.
  • 8. Figure 33.6 © 2012 Pearson Education, Inc.
  • 9. 33.3 Diphtheria and Pertussis • Diphtheria – A severe respiratory disease that typically infects children – Caused by Corynebacterium diphtheriae • A bacterium that forms irregular rods during growth – Preventable and treatable © 2012 Pearson Education, Inc.
  • 10. Figure 33.7a © 2012 Pearson Education, Inc.
  • 11. 33.3 Diphtheria and Pertussis • Corynebacterium diphtheriae – Spreads by airborne droplets and enters the body via the respiratory route – Previous infection or immunization provides resistance – Pathogenic strains lysogenized by bacteriophage  produce a powerful exotoxin that causes • Tissue death • The appearance of the pseudomembrane in the patient’s throat © 2012 Pearson Education, Inc.
  • 12. Figure 33.7b © 2012 Pearson Education, Inc.
  • 13. 33.3 Diphtheria and Pertussis • Diagnosis of Diphtheria – C. diphtheriae must be isolated from the throat • Prevention of Diphtheria – Vaccine • Treatment of Diphtheria – Antibiotics – Diphtheria antitoxin available for acute cases • Early administration necessary © 2012 Pearson Education, Inc.
  • 14. 33.3 Diphtheria and Pertussis • Pertussis (whooping cough) – An acute, highly infectious respiratory disease – Caused by infection with Bordetella pertussis – Observed frequently in school-age children – Characterized by a recurrent, violent cough – There has been a consistent upward trend of infections since the 1980s – Inadequately immunized children, adolescents, and adults are at high risk for acquiring and spreading pertussis © 2012 Pearson Education, Inc.
  • 15. Figure 33.8 Year 1977 1982 1987 1992 1997 2002 2007 9 8 7 6 5 4 3 2 1 0 Pertussis (incidence per 100,000 population) © 2012 Pearson Education, Inc.
  • 16. 33.3 Diphtheria and Pertussis • Diagnosis – Made by fluorescent antibody staining of a nasopharyngeal swab specimen – Also made by actual culture of the organism • Prevention – Vaccine soon after birth • Treatment – Antibiotics – But elimination is helped by the immune response © 2012 Pearson Education, Inc.
  • 17. 33.4 Mycobacterium, Tuberculosis, and Hansen’s Disease • Tuberculosis is caused by Mycobacterium tuberculosis • Hansen’s disease (leprosy) is caused by Mycobacterium leprae • All mycobacteria are acid-fast due to the waxy mycolic acid content of their cell walls © 2012 Pearson Education, Inc.
  • 18. Figure 33.9 © 2012 Pearson Education, Inc.
  • 19. 33.4 Mycobacterium, Tuberculosis, and Hansen’s Disease • Tuberculosis – Worldwide infectious disease of humans – Incidence is increasing – M. tuberculosis transmitted by airborne droplets – Cell-mediated immunity plays a critical role in the prevention of active disease after infection – Classified as a primary (initial) infection or postprimary infection (reinfection) © 2012 Pearson Education, Inc.
  • 20. Figure 33.10 © 2012 Pearson Education, Inc.
  • 21. 33.4 Mycobacterium, Tuberculosis, and Hansen’s Disease • Spread of tuberculosis is prevented by – Hospitalization of patients in negative-pressure rooms – Use of face masks for healthcare workers • Treatment – Antimicrobial therapy with isoniazid • Treatment usually requires a 9-month regimen • Affects the synthesis of mycolic acid in mycobacteria © 2012 Pearson Education, Inc.
  • 22. 33.4 Mycobacterium, Tuberculosis, and Hansen’s Disease • Hansen’s disease (leprosy) – M. leprae is the causative agent – The armadillo is the only experimental animal that has been successfully used to grow M. leprae – Most serious form is characterized by folded, bulblike lesions on the body © 2012 Pearson Education, Inc.
  • 23. Figure 33.12 © 2012 Pearson Education, Inc.
  • 24. 33.4 Mycobacterium, Tuberculosis, and Hansen’s Disease • Pathogenicity of M. leprae – Due to a combination of delayed hypersensitivity and the invasiveness of the organism – Transmission is by both direct contact and respiratory routes – Incubation times vary from several weeks to years – The incidence of leprosy worldwide is low © 2012 Pearson Education, Inc.
  • 25. 33.6 Viruses and Respiratory Infections • Viruses are less easily controlled by chemotherapeutic methods • The most prevalent human infections are caused by viruses • Most viral diseases are acute, self-limiting infections • A few serious viral diseases have been effectively controlled by vaccination (e.g., smallpox and rabies) © 2012 Pearson Education, Inc.
  • 26. 33.6 Viruses and Respiratory Infections • Measles (rubeola or 7-day measles) – Often affects susceptible children as an acute, highly infectious, often epidemic disease (Figure 33.14) – Caused by a paramyxovirus • Negative-strand RNA virus – Virus enters the nose and throat by airborne transmission © 2012 Pearson Education, Inc.
  • 27. Figure 33.14 © 2012 Pearson Education, Inc.
  • 28. 33.6 Viruses and Respiratory Infections • Measles (cont’d) – Used to be a common childhood illness – Now only occurs in rather isolated outbreaks • Due to widespread immunization programs that began in the mid-1960s – Over 600,000 deaths per year worldwide – Proof of immunization required for enrollment in U.S. public schools © 2012 Pearson Education, Inc.
  • 29. 33.6 Viruses and Respiratory Infections • Mumps – Caused by a paramyxovirus (like measles) – Highly infectious – Spread by airborne droplets – Characterized by inflammation of the salivary glands © 2012 Pearson Education, Inc.
  • 30. Figure 33.16 © 2012 Pearson Education, Inc.
  • 31. 33.6 Viruses and Respiratory Infections • Rubella (German measles or 3-day measles) – Caused by a positive-strand RNA virus of the togavirus group – Disease symptoms resemble measles but are generally milder and less contagious – Routine childhood immunization is practiced in the U.S. © 2012 Pearson Education, Inc.
  • 32. 33.6 Viruses and Respiratory Infections • In the U.S., the incidence of measles, mumps, and rubella has decreased significantly since the implementation of the MMR vaccine © 2012 Pearson Education, Inc.
  • 33. Figure 33.15 Measles Mumps Rubella 1987 1992 1997 2002 2007 2012 19651970197519801985 400 200 0 1987 1992 1997 2002 2007 2012 19651970197519801985 1987 1992 1997 2002 2007 2012 19651970197519801985 1960 150 100 50 0 0 10 20 30 25 20 15 10 5 0 5 6 7 4 3 2 1 0 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0 Cases per 100,000 population Cases per 100,000 population Cases per 100,000 population Vaccine licensed © 2012 Pearson Education, Inc.
  • 34. 33.6 Viruses and Respiratory Infections • Chicken pox (varicella) – Common childhood disease characterized by a systemic papular rash – Caused by varicella-zoster virus (VZV), a herpesvirus – VZV is highly contagious and transmitted by infectious droplets – A vaccine is presently used in the U.S. © 2012 Pearson Education, Inc.
  • 35. Figure 33.17 © 2012 Pearson Education, Inc.
  • 36. 33.6 Viruses and Respiratory Infections • Chicken pox (cont’d) – VZV virus establishes a lifelong latent infection in nerve cells – The virus occasionally migrates to the skin surface, causing a painful skin eruption (shingles) © 2012 Pearson Education, Inc.
  • 37. 33.7 Colds • Colds – Viral infections transmitted via airborne droplets – Infections are usually of short duration – Symptoms milder than other respiratory diseases – Symptoms include rhinitis, nasal obstruction, watery nasal discharges, and malaise © 2012 Pearson Education, Inc.
  • 38. Figure 33.18 Cases per 100 people per year All other infectious diseases Colds Influenza 400 300 200 100 0 © 2012 Pearson Education, Inc.
  • 39. 33.7 Colds • The Common Cold – Commonly caused by rhinoviruses (Figure 33.19) • Positive-sense, single-stranded RNA viruses • Nearly 115 different strains identified – Approximately 15% of colds are due to coronaviruses – Approximately 10% of colds are due to other viruses © 2012 Pearson Education, Inc.
  • 40. Figure 33.19 © 2012 Pearson Education, Inc.
  • 41. 33.7 Colds • Each cold infection induces a specific, protective immunity, but the large number of viral cold pathogens precludes complete protective immunity or vaccines © 2012 Pearson Education, Inc.
  • 42. 33.8 Influenza • Influenza is caused by an RNA virus of the orthomyxovirus group • There are three different types of influenza viruses (A, B, C) • Influenza A is the most important human pathogen © 2012 Pearson Education, Inc.
  • 43. Figure 33.21 HA trimer Lipid bilayer M protein NA tetramer RNA NP PA, PB1, PB2 © 2012 Pearson Education, Inc.
  • 44. 33.8 Influenza • Influenza outbreaks occur annually due to the plasticity of the influenza genome – Antigenic shift • Major change in influenza virus antigen due to gene reassortment (Figure 33.22) – Antigenic drift • Minor change in influenza virus antigens due to gene mutation © 2012 Pearson Education, Inc.
  • 45. Figure 33.22 Reassortant virus Human virus Bird virus Infection with bird virus Reassortment of human and bird virus Infection with human virus Infection with reassortant virus © 2012 Pearson Education, Inc.
  • 46. 33.8 Influenza • Influenza epidemics and pandemics occur periodically – 1957 outbreak of Asian flu – 1997 outbreak of avian influenza © 2012 Pearson Education, Inc.
  • 47. Figure 33.23 Country of origin Countrywide epidemic Localized outbreaks Routes of spread © 2012 Pearson Education, Inc.
  • 48. 33.8 Influenza • Prevention – Immunization – Careful worldwide surveillance • Treatment – Use of various drugs – Most effective when administered early – Aspirin should be avoided © 2012 Pearson Education, Inc.
  • 49. 33.11 Hepatitis Viruses • Hepatitis – Liver inflammation caused by viruses or bacteria – Sometimes results in acute illness followed by destruction of liver anatomy and cells (cirrhosis) – A restricted group of viruses is associated with liver disease – Hepatitis viruses are diverse © 2012 Pearson Education, Inc.
  • 50. 33.11 Hepatitis Viruses • Hepatitis A virus (infectious hepatitis) – Causes mild or, rarely, severe cases of liver disease • Hepatitis B virus (serum hepatitis; Figure 33.27) – Causes acute, often severe disease that can lead to liver failure and death • Hepatitis D virus – A defective virus that cannot replicate and express a complete virus unless the cell is also infected with hepatitis B © 2012 Pearson Education, Inc.
  • 51. Figure 33.27 © 2012 Pearson Education, Inc.
  • 52. 33.11 Hepatitis Viruses • Hepatitis C virus – Produces a mild disease initially, but most individuals develop chronic hepatitis that can lead to chronic liver disease © 2012 Pearson Education, Inc.
  • 53. 33.11 Hepatitis Viruses • Incidence and Prevalence of Hepatitis – Decreased significantly in the U.S. in the last 20 years (Figure 33.26) – Viral hepatitis is still a major public health problem • Due to the high infectivity of the viruses and the lack of effective treatment options – Vaccines are available for Hepatitis A and B viruses © 2012 Pearson Education, Inc.
  • 54. Figure 33.26 Hepatitis A Hepatitis B Hepatitis C HAV vaccine 1995 HBV vaccine 1982 Year Cases per 100,000 population 20 15 10 5 0 1975 1980 1985 1990 1995 2000 2005 2010 © 2012 Pearson Education, Inc.
  • 55. III. Sexually Transmitted Infections • Sexually Transmitted Infections (STIs) – Also called sexually transmitted diseases (STDs) or venereal diseases – Caused by a variety of bacteria, viruses, protists, and even fungi – Pathogens are generally only found in body fluids from the genitourinary tract that are exchanged during sexual activity © 2012 Pearson Education, Inc.
  • 56. 33.12 Gonorrhea and Syphilis • Gonorrhea and syphilis are preventable, treatable bacterial STIs • The overall pattern of disease differs between the two – Gonorrhea is prevalent and often asymptomatic in women – Syphilis has low prevalence and exhibits very obvious symptoms © 2012 Pearson Education, Inc.
  • 57. Figure 33.28 Year Birth control pills Penicillin World War II Reported cases per 100,000 population Syphilis Gonorrhea 500 400 300 200 100 0 1920 1925 1930 1935 1940 1945 1950 1955 1960 1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 © 2012 Pearson Education, Inc.
  • 58. 33.12 Gonorrhea and Syphilis • Gonorrhea – Caused by Neisseria gonorrhoeae – Symptoms in females • Characterized by a mild vaginitis that often goes unnoticed • Untreated gonorrhea can lead to pelvic inflammatory disease – Symptoms in males • Characterized by a painful infection of the urethral canal © 2012 Pearson Education, Inc.
  • 59. Figure 33.29 © 2012 Pearson Education, Inc.
  • 60. 33.12 Gonorrhea and Syphilis • Syphilis – Caused by Treponema pallidum – Often transmitted at the same time as gonorrhea – T. pallidum can be transmitted from an infected woman to the fetus during pregnancy (congenital syphilis) – Three stages: primary, secondary, and tertiary – Penicillin highly effective for primary and secondary stages © 2012 Pearson Education, Inc.
  • 61. Figure 33.30 © 2012 Pearson Education, Inc.
  • 62. 33.13 Chlamydia, Herpes, and HPV • Chlamydia trachomatis causes a number of sexually transmitted diseases – Nongonococcal urethritis (NGU) – Lymphogranuloma venereum © 2012 Pearson Education, Inc.
  • 63. Figure 33.32 © 2012 Pearson Education, Inc.
  • 64. 33.13 Chlamydia, Herpes, Trichomoniasis, and HPV • Herpes simplex 1 virus (HSV-1) – Infects the epithelial cells around the mouth and lips – Causes cold sores – May occasionally affect other body sites – Spread via direct contact or through saliva – Lesions heal without treatment in 2 to 3 weeks © 2012 Pearson Education, Inc.
  • 65. 33.13 Chlamydia, Herpes, Trichomoniasis, and HPV • Herpes simplex 2 virus (HSV-2) – Infections are associated primarily with anogenital region – Causes painful blisters on penis of male and cervix, vulva, or vagina of females – Typically transmitted through sexual contact and most easily transmitted when active blisters are present – Genital herpes are presently incurable, however, a limited number of drugs are successful in controlling the infectious blister stage © 2012 Pearson Education, Inc.
  • 66. 33.13 Chlamydia, Herpes, Trichomoniasis, and HPV • Human papillomavirus (HPV) – Causes several different infections • Many infections are asymptomatic but some progress to genital warts • Can cause cervical neoplasia, and a few progress to cervical cancers – There is an effective HPV vaccine © 2012 Pearson Education, Inc.
  • 67. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • AIDS – Recognized as a distinct disease in 1981 – Human immunodeficiency virus (HIV) is the causative agent • HIV – As many as 1.4 million people worldwide may be infected © 2012 Pearson Education, Inc.
  • 68. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • HIV is divided into two types: – HIV-1 is the more virulent type – HIV-2 is less virulent and causes a milder, AIDS- like disease • Opportunistic infections are common in AIDS patients © 2012 Pearson Education, Inc.
  • 69. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • A frequent nonmicrobial disease in AIDS patients is Kaposi’s sarcoma, an atypical cancer © 2012 Pearson Education, Inc.
  • 70. Figure 33.37 © 2012 Pearson Education, Inc.
  • 71. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • HIV Pathogenesis – HIV infects cells that contain the CD4 cell surface protein – Most commonly infected are macrophages and T-helper cells – HIV also interacts with coreceptors on target cells © 2012 Pearson Education, Inc.
  • 73. Figure 33.39 Nucleocapsid Nucleus gp 120 CCR5 CD4 Target cell Interaction of HIV with a host cell Fusion of the HIV envelope with the host cell HIV gp120 protein binds CD4 receptor and CCR5 receptor Interaction of the virus with a receptor– coreceptor pair on the host cell The viral envelope and host membrane coalesce The nucleocapsid is inserted into the host cell, beginning the viral infection HIV © 2012 Pearson Education, Inc.
  • 74. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • HIV infection does not immediately kill the host cell • Infection results in a progressive decline in CD4 cells • As the number of CD4 cells declines, cytokine production falls, leading to reduction of the immune response © 2012 Pearson Education, Inc.
  • 75. Figure 33.40 Symptom- free Swollen lymph glands Subclinical immune dysfunction Oppor- tunistic infections Systemic immune deficiency Time (months) after HIV exposure HIV RNA copies per ml Death CD4 T cells per mm3 of blood Normal range for T cells Significantly depressed T cells Severe T cell depletion 106 104 102 1000 900 800 700 600 500 400 300 200 100 0 0 6 12 18 24 30 36 42 48 54 60 66 72 78 84 © 2012 Pearson Education, Inc.
  • 76. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • HIV infection can be diagnosed with an HIV-EIA, HIV-immunoblot, or rapid tests – These fail to detect infection in individuals who recently acquired the HIV and have not made a detectable antibody • RT-PCR can detect HIV RNA directly from blood and estimate the number of viruses present – This is useful for early detection and monitoring the progression of infection © 2012 Pearson Education, Inc.
  • 77. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • Treatment – Four classes of drugs delay the symptoms of AIDS and prolong the life of those infected with HIV • Nucleoside reverse transcriptase inhibitors • Nonnucleoside reverse transcriptase inhibitors • Protease inhibitors • Fusion inhibitors – Highly active antiretroviral therapy (HAART) is used © 2012 Pearson Education, Inc.
  • 78. 33.14 Acquired Immunodeficiency Syndrome: AIDS & HIV • There is not an effective vaccine for HIV • Prevention for the spread of HIV infection requires education and avoidance of high-risk behavior © 2012 Pearson Education, Inc.

Editor's Notes

  1. Figure 33.1 High-speed photograph of an unstifled sneeze.
  2. Figure 33.3 Streptococcus pathogens.
  3. Figure 33.4 Typical lesions of impetigo.
  4. Figure 33.5 Erysipelas.
  5. Figure 33.6 Scarlet fever.
  6. Figure 33.7 Corynebacterium and diphtheria.
  7. Figure 33.7 Corynebacterium and diphtheria.
  8. Figure 33.8 Bordetella and pertussis.
  9. Figure 33.9 Mycobacteria.
  10. Figure 33.10 Tuberculosis X-ray.
  11. Figure 33.12 Lepromatous leprosy lesions on the skin.
  12. Figure 33.14 Measles in children.
  13. Figure 33.16 Mumps.
  14. Figure 33.15 Viral diseases and vaccines.
  15. Figure 33.17 Chicken pox.
  16. Figure 33.18 Colds and influenza.
  17. Figure 33.19 Common cold viruses.
  18. Figure 33.21 Electron micrograph of influenza virus.
  19. Figure 33.22 Influenza virus reassortment.
  20. Figure 33.23 An influenza pandemic.
  21. Figure 33.27 Hepatitis B virus (HBV).
  22. Figure 33.26 Hepatitis in the United States.
  23. Figure 33.28 Reported cases of gonorrhea and syphilis in the United States.
  24. Figure 33.29 The causative agent of gonorrhea, Neisseria gonorrhoeae.
  25. Figure 33.30 The syphilis spirochete, Treponema pallidum.
  26. Figure 33.32 Cells of Chlamydia trachomatis (arrows) attached to human fallopian tube tissues.
  27. Figure 33.37 Kaposi’s sarcoma.
  28. Figure 33.38 Human lymphocyte releasing HIV.
  29. Figure 33.39 Infection of a CD4 target cell with the AIDS virus, HIV.
  30. Figure 33.40 Decline of CD4 T lymphocytes and progress of HIV infection.